EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

11.24.16

Patent Quality at the EPO Depends on the Future of the Boards of Appeal (Which Battistelli is Killing Not So Softly)

Posted in Europe, Patents at 2:04 pm by Dr. Roy Schestowitz

One of the few singles I happen to have the CD of…

Killing Me Softly

Summary: The decline in patent quality at the EPO is bad news not just for applicants but for all Europeans, and there’s no sign of it improving any time soon (under Battistelli to whom quality is an impediment)

THE EPO was a world-leading patent office for decades; it did not have many patents and this was actually a good thing because it meant that each single EP was of very high quality and there was certainty about it inside and outside the court (less risk, less litigation). Unlike the USPTO, the EPO did strive to maintain quality, which resulted in high fees. The EPO basically did what every patent office should do, but a lot of that changed when it got greedy and in defiance of Parliamentary instructions started granting software patents (covertly, using excuses and loopholes it had created) and patents on life, e.g. seeds, plants, animals. Patent maximalism further accelerated under Battistelli, a person so anti-scientific (crudely speaking, a chickenhawk politician) that he would never manage to come up with a valid patent of his own.

Nowadays, the EPO ignores the European Commission on everything including patent scope, so the rules don’t seem to matter to it. The notion of “rules” hardly even exists at the EPO; what exists can be described as Presidential decrees. Here is a new “international report” from Bart W Swinkels of NLO (European Union). It says the following:

European Commission notice against patentability of plants does not affect European plant patents

On November 3 2016 the European Commission issued a notice regarding the patentability of plants and animals obtained by means of essentially biological processes.

In the view of the commission, the EU legislature’s intention when adopting EU Directive 98/44/EC “was to exclude from patentability products (plants/animals and plant/animal parts) that are obtained by means of essentially biological processes”.

However, the commission’s notice is not legally binding; it is up to the courts and boards – not the commission – to interpret the law.

In other words, as usual, the EPO does whatever the Hell it wants, no matter if it makes it look arrogant, foolish, even corrupt. See this tweet posted today by the EPO. Very vague (but familiar to us) language is being used to masquerade/blur the inclusion of software patents in an upcoming event (yet again! Warning: epo.org link). Based on what EPO examiners say, they no longer have much time to properly search prior art and they actually grant patents on software. They are under too much pressure under their management to “produce” (where production usually gets measured in teams of “products”, not actual work). Watch what the EPO wrote today. It’s totally out of touch!

“In other words, as usual, the EPO does whatever the Hell it wants, no matter if it makes it look arrogant, foolish, even corrupt.”One of our remaining hopes is that the appeal boards will shake things up a bit. The supposedly independent judges need to remind the Office that it cannot just pursue greater quantity of patents by disregarding quality, thereby essentially spitting in the well (or muddying the water) of EPs’ value.

According to this new announcement, quality control is not entirely dead at the EPO. To quote a press releases about it, “BMO Capital analyst, Matthew Luchini, reiterated his Outperform rating on shares of Alder Biopharm (NASDAQ: ALDR) despite shares being under pressure following the European Patent Office’s (EPO) oral decision, which revoked Teva’s patent claims related to CGRP antagonist antibodies for the treatment of migraine but maintained and narrowed method of use claims.”

Here is another new bit of coverage that says “Aegis Capital affirms Alder Biopharmaceuticals (Nasdaq: ALDR) at Buy with a price target of $41 after the EPO maintained claims related to CGRP use in Migraines.

“The supposedly independent judges need to remind the Office that it cannot just pursue greater quantity of patents by disregarding quality, thereby essentially spitting in the well (or muddying the water) of EPs’ value.”“Analyst Difei Yang sees the recent pullback in ALDR shares as a buying opportunity. The analyst commented, “The EPO’s ruling is certainly a setback in the intellectual property legal proceedings of Alder and Eli Lilly, however it is also, in our view, a buying opportunity as the valuation impact to Alder is minimal; an approximate $2 per share decrease from our estimated price target. This reasoning stems from our opinion that there will be limited, if any, carry over to the US, where the large bulk of the future value of ALD-403 is based.””

Here, in this particular example, we’re dealing with patents on drugs, not software, but the principles of patent scope still apply. Consider this new “international report” published yesterday by IAM. It says “Yeda Research and Development Company owned a patent directed to a monoclonal antibody that selectively binds and purifies the human cytotoxin, tumor necrosis factor (TNF).”

“To Battistelli, patent quality control is just some nuisance that stands in the way of his terrible goal of “production” (as measured by the ‘SIPO yardstick’).”As we noted here before, restrictive patent scope is needed in the area of cancer as well, otherwise patients will be killed for the sake of corporate profits. Societal cost analysis suggests that patents should be few but solid. We are not at all against patents (never were!); we’re in favour of high quality patents whose grant can be justified by taking into account externalities like human life.

Battistelli, as this new tweet serves to remind us, is ensuring there’s not much left to preserve patent quality at the EPO (appeals are becoming too expensive, the boards understaffed, no independence). To Battistelli, patent quality control is just some nuisance that stands in the way of his terrible goal of “production” (as measured by the 'SIPO yardstick').

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Bristows is Being Hammered With Negative Comments For Its Unitary Patent (UPC) Lies

    The Unified Patent Court (UPC) is practically dead in the UK and Ireland; Bristows, nevertheless, continues with its desperate spin



  2. Links 11/12/2017: Linux 4.15 RC3, Debian 8.10 and Debian 9.3

    Links for the day



  3. Judge Corcoran Turns to His Government for Help and EPO 'House Ban' is Finally Lifted

    Sources that are very reliable say that Patrick Corcoran is coming back to work, however it's now clear when and how long for



  4. Raw: Battistelli's Control/Domination Over the Boards of Appeal

    An old EPO document internally voicing concerns about the lack of independence at the Boards of Appeal



  5. Raw: Conflicts of Interest of EPO Vice-President

    An old EPO concern regarding structural collisions and mixed loyalties



  6. Microsoft-Connected Patent Trolls Are Increasingly Active and Microsoft is Selling 'Protection' (Azure Subscriptions)

    There are several indications that Microsoft-connected shells, which produce no products and are threatening a large number of companies, are inadvertently if not intentionally helping Microsoft sell "indemnification" ("Azure IP Advantage," which echoes the Microsoft/Novell strategy for collecting what they called "patent royalties" one decade ago)



  7. Yes, RPost is Definitely a Patent Troll and Its Software Patents Are at Risk Thanks to Alice

    The latest whitewashing (or reputation-laundering) pieces from Watchtroll, which tries to justify patent-trolling activities with software patents, typically in the Eastern District of Texas



  8. The Latest Scams in the Patent World

    Examples of 'dirty laundry' of the patent microcosm, which it understandably does not like covering (as it harms confidence in their services/advice)



  9. Patents Are Becoming a Welfare System for the Rich and Powerful

    A culture of litigation and more recently the patenting of broad industry standards may mean that multi-billion dollar corporations are cashing in without lifting a finger



  10. Unlike the Mobile Domain, When it Comes to Cars Patent Lawsuits Remain Rare

    An optimistic note regarding the relatively low-temperature legal landscape surrounding advanced automobiles, even though patents are being amassed on software in that domain



  11. The Federal Circuit Rules (Again) in Favour of Section 101/Alice, Koch-Funded CPIP Tries to Overturn Alice at the Supreme Court

    The US Supreme Court's decision on Alice continues to have a profoundly positive impact (except for trolls) and Koch-funded academics try hard to compel the US Supreme Court to reverse/override Alice (so far to no avail)



  12. Next Director of the USPTO Parrots Talking Points of Patent Extremists and Their Lobbyists

    The next USPTO boss (still subject to official confirmation) may be little more than a power grab by the litigation and patenting 'industry', which prioritises not science and technology but its own bottom line



  13. Raw: Three Years for 'Justice' (to be Disregarded by Benoît Battistelli) at ILO and Over a Decade at the EPO

    The delays associated with ‘justice’ at the EPO (usually neither justice nor compliance with rulings) have become so extraordinary that immunity should long ago have been stripped off and Battistelli et al been held accountable



  14. Raw: Scuttling of the General Advisory Committee and Battistelli Stacking the Deck to Have 'Yes Men' as Representatives

    How the EPO broke down resistance to Battistelli’s oppressive policies not only at the Council, disciplinary committees and auditory divisions but also staff representation (symptomatic of Battistelli’s notion of justice)



  15. The Patent Trial and Appeal Board Will Endure Supreme Court Test and Overcome the Tribal Immunity “Scam”

    The Patent Trial and Appeal Board (PTAB), based on the latest news, is still winning the argument and justifying its existence/importance



  16. Phones/Mobility (Trillion-Dollar Market) May Have Become Infested and Encumbered by Aggressive, Dying Companies

    The tough reality that new entrants/entrepreneurs are facing now that a few dying giants look to "monetise" their patents rather than create anything



  17. Links 9/12/2017: Mesa 17.3, Wine 3.0 RC1, New Debian Builds

    Links for the day



  18. Like the EPO, Taiwan/China (SIPO) Harm SMEs With a Policy of Patent Maximalism Which Fosters Litigation, Not Innovation

    A culture of patent maximalism breeds plenty of lawsuits in China (good for the legal ‘industry’), but small companies that are innovative lose focus and resources, just like in Europe where SMEs are discriminated against



  19. Bristows Continues to Lie About Unitary Patent (UPC) in Britain Only to Get Rebutted in Comments, As Usual (Criticism Not Deleted Yet)

    The latest wave of posts (typically from Bristows) which herald an arrival of UPC in Britain are not just delusional but also constitute terrible legal advice



  20. The European Union Now Repeats Paid Propaganda From the EPO (Regarding the Unitary Patent)

    The EPO's push for UPC, which has already involved payments to media and academia, is spreading to the EU, which unfortunately fails to uphold the Rule of Law and the spirit of the EPC



  21. European Media Covers the Latest EPO Scandal and the EPO's Refusal to Obey Orders of a Court

    European media is starting to catch up with the latest from ILO and the great importance not only of the rulings but also the EPO's response to these



  22. Antonius Tangena From the European Patent Institute (EPI) 'Aids' Željko Topić's Appointment at the European Patent Office (EPO)

    An E-mail from Antonius (Tony) Tangena reveals a degree of coordination between the EPI and the EPO -- a potentially inappropriate action that can be seen as a cover-up attempt



  23. SUEPO Announces Protest, EPO Distracts From the Scandal, and Readers Spill the Beans

    Readers have sent some additional details regarding the EPO "backstory" that we wrote about this morning



  24. EPO Scandal Spills Over to Irish Media, So It's Time for the Backstory

    A lot more is being revealed by the media this week (regarding the EPO's "war on judges") and now that it's a more 'mainstream' subject we can shed light on the background to it



  25. Battistelli's EPO is Once Again Caught in Very Gross Violation of the European Patent Convention (EPC)

    The tyranny of the EPO is made abundantly clear for all to see -- ILO included -- but will there be consequences for repeated violations by Team Battistelli?



  26. Links 7/12/2017: Qt 5.10, ReactOS 0.4.7, Guix and GuixSD 0.14.0

    Links for the day



  27. Less Than 24 Hours Later the EPO Already Refuses to Obey Court Orders From ILO (Updated)

    As expected by realists (or pessimists), the EPO continues to act as though it's above the law and even judges suffer miscarriage of justice against them



  28. ILO Said Give the Judge His Job Back, But Christoph Ernst's Administrative Council Will Likely Let Him Go (Unemployed)

    Another potential EPO scandal in the making, as after waiting for 3 years the illegally-suspended judge might get his job back for only 3 weeks



  29. Watchtroll, AIPPI, Bristows and Others Keep Pushing Software Patents Agenda (in Spite of the Ban)

    Pressure groups and front groups of the patent microcosm (e.g. AIPPI) -- sometimes even the patent microcosm acting directly -- are still trying to make software patents legitimate, usually behind closed doors, e.g. in private events where only the patent microcosm can debate the subject (no software developers allowed)



  30. Meanwhile in Eponia, Tyrant Battistelli Must be Seeking Advice on How to Refuse to Obey Court's Orders (Again)

    People already speculate about how Battistelli will attempt to come up with excuses for noncompliance (and ongoing violation of the EPC as well as ILO code)


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts